Clinical Trial Update: Prospective Study of Mylotarg and G-CSF in Acute Myeloid Leukemia Treatment [Phase 2]

View source ↗

Summary

A Phase 2 prospective study evaluating Mylotarg (gemtuzumab ozogamicin) with G-CSF in Novo Acute Myeloid Leukemia has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Mylotarg (gemtuzumab ozogamicin)

Snippet

Sponsor: Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias | Conditions: Novo Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2021-01-27